Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Volume XXXI, No. 5 - April 8, 2024

Lab Market Is Fragmenting, Creating New Opportunities

Even as consolidation continues in the ownership of hospitals, health systems, office-based physicians, and clinical laboratories, there is a powerful trend of fragmentation quietly transforming the way providers—including clinical labs and pathology groups—serve patients and consumers who want specialized expertise and choice. Today’s market for clinical laboratory testing services is fragmenting at a pace that …

Lab Market Is Fragmenting, Creating New Opportunities Read More »

To access this post, you must purchase The Dark Report.

Are Lab Leaders Ready for Artificial Intelligence?

WITH ASTONISHING SWIFTNESS, ARTIFICIAL INTELLIGENCE (AI) HAS BECOME PROBABLY THE SINGLE MOST IMPORTANT TECHNOLOGY discussed in corporate boardrooms and management meetings today. This is as true for clinical labs and pathology groups as it is for Fortune 100 corporations. Almost daily, there are headlines about the inroads AI is making into different aspects of business …

Are Lab Leaders Ready for Artificial Intelligence? Read More »

To access this post, you must purchase The Dark Report.

Lab Market Fragmenting, Creating New Opportunities

CEO SUMMARY: Even as consolidation continues in the ownership of hospitals, health systems, office-based physicians, and clinical laboratories, there is a powerful trend of fragmentation quietly transforming the way providers—including clinical labs and pathology groups—serve patients and consumers who want specialized expertise and choice. Today’s market for clinical laboratory testing services is fragmenting at a pace …

Lab Market Fragmenting, Creating New Opportunities Read More »

To access this post, you must purchase The Dark Report.

FDA Issues Memo to Reclassify Many High Risk IVD Assays

WAS IT AN EXPECTED FLOOD OF APPLICATIONS TO REVIEW laboratory developed tests (LDTs) that motivated the federal Food and Drug Administration’s (FDA’s) Center for Devices and Radiological Health (CDRH) to declare its intention “to initiate the reclassification process for most IVDs that are currently class III (high risk) into class II (moderate risk)” in a …

FDA Issues Memo to Reclassify Many High Risk IVD Assays Read More »

To access this post, you must purchase The Dark Report.

Walgreens to Close 60 VillageMD Locations

CEO SUMMARY: Following substantial losses in fiscal 2023, Walgreens is working to cut costs and reduce overhead. One casualty in this effort will be the closure of 60 of the 360 primary care clinics in retail pharmacy stores built by Walgreens in recent years. These actions demonstrate that putting primary care clinics into drugs stores …

Walgreens to Close 60 VillageMD Locations Read More »

To access this post, you must purchase The Dark Report.

Pathologist Paul A. Brown, MD, MetPath Founder, Dies at 85

EARLIER THIS YEAR, THE PATHOLOGY PROFESSION LOST one of what some call “the two Lions of Pathology.” On January 24, 2024, Paul A. Brown, MD, aged 85, died at his home in Palm Beach, Florida. In 1967, Brown was the founder of Metropolitan Pathology Laboratory, Inc., based in New York City and known as MetPath. …

Pathologist Paul A. Brown, MD, MetPath Founder, Dies at 85 Read More »

To access this post, you must purchase The Dark Report.

April 8, 2024, Intelligence: Late-Breaking Lab News

UnitedHealth Group stated that the cyberattack against Change Healthcare, a business unit of UnitedHealth’s Optum division, disrupted processing of approximately $14 billion in claims. The company discovered the cyberattack on Feb. 21 and said it disconnected the data systems targeted in the attack. UnitedHealth also stated that its software system for preparing medical claims, named …

April 8, 2024, Intelligence: Late-Breaking Lab News Read More »

To access this post, you must purchase The Dark Report.

Final Rule on AI Transparency Can Benefit Clinical Labs

ARTIFICIAL INTELLIGENCE (AI) AND MACHINE LEARNING are becoming ubiquitous in today’s modern hospital systems and clinical laboratories. In response to these developments, federal officials issued a new rule that has major implications on how healthcare providers use artificial intelligence. This article is the second part of a report by The Dark Report that discusses The …

Final Rule on AI Transparency Can Benefit Clinical Labs Read More »

To access this post, you must purchase The Dark Report.

;